4A,B) and hydrolyzed ATP faster and produced more adenosine than circulating mDCs (Fig. 4C,D). We next tested the responses of liver mDCs from WT or CD39−/− B6 mice to ATP, in the absence or presence of the TLR4 ligand, LPS, MAMP to which liver-resident APCs are exposed continually under steady-state conditions. LPS stimulation and combined ATP plus LPS stimulation modestly up-regulated MHC II and coregulatory molecule expression on liver mDCs from WT and, especially, those from CD39−/− mice (Fig. 5A). Moreover, CD39−/− liver mDCs secreted significantly greater quantities of proinflammatory cytokines in response to LPS ± ATP stimulation, compared to WT liver DCs (Fig. 5B). CD39−/− liver mDCs also exhibited selleck chemicals llc stronger

naïve T-cell allostimulatory ability and induced more interferon-gamma (IFN-γ)+CD8+ T cells in MLR (Fig. 5C,D). These data suggest that CD39 contributes to the immune regulatory function of liver mDCs. Absolute numbers of liver mDCs and all other liver and spleen leukocyte populations examined were preserved in CD39−/− mice (Supporting Table 1). There was also no significant difference between WT and CD39−/− CD4 and CD8

T cells in their expression of cell-surface activation Metabolism inhibitor markers (Supporting Fig. 2A) or their proliferative capacity after anti-CD3/CD28 bead or allogeneic DC stimulation (Supporting Fig. 2B). However, compared to those from WT mice, splenic Tregs from CD39−/− mice exhibited a reduced suppressive function on effector T-cell proliferation (Supporting Fig. 2C). To examine the in vivo functional significance of CD39 in LT-associated cold IRI, CD39−/− or WT livers were transplanted into syngeneic (B6) WT recipients with 24-hour cold preservation, as previously described.[37] CD39−/− liver grafts elicited significantly higher levels of serum ALT and AST than WT 上海皓元 grafts after 6-hour reperfusion (Fig. 6A). Histological analysis confirmed more-extensive areas of necrosis and elevated Suzuki scores in CD39−/− liver grafts (Fig. 6B,C). Circulating IL-6, IL-12p40, and TNF-α levels were all significantly higher in mice

with CD39−/− grafts (Fig. 6D), correlating with higher levels of production of these cytokines by CD39−/− liver mDCs in vitro (Fig. 5B). Freshly isolated mDCs from CD39−/− grafts (6 hours post-transplant) expressed higher levels of cell-surface maturation markers and lower levels of coinhibitory B7-H1 (PD-L1), compared to DC from WT liver grafts (Fig. 6E). Moreover, increased levels of proinflammatory cytokines were observed in grafts from CD39−/− donors (Fig. 6F). These results suggest that, as a result of the absence of CD39, unhydrolyzed ATP activated liver mDCs and exacerbated cold I/R injury. To verify a protective role of CD39 on liver mDCs in vivo, we also examined cold IRI in CD39−/− recipients of CD39−/− liver grafts that received WT or CD39−/− liver mDCs intraportally, immediately after liver implantation.